Výsledky vyhledávání - "Laura H Hendrix"

Akademický článek

Safety, adherence and discontinuation in varenicline solution nasal spray clinical trials for dry eye disease

Autor: Alan G Kabat, Mandy Hemphill, Karan Somaiya, Laura H Hendrix, Andrea A Gibson

Publikováno v: Journal of Comparative Effectiveness Research, Vol 12, Iss 6 (2023)

Aim: Herein, we report safety outcomes for varenicline solution nasal spray (VNS) within the context of clinical trial discontinuation, contrasting those with discontinuation outcomes from topical cyclosporine and lifitegrast clinical trials. Mater

Externí odkaz: https://doaj.org/article/ae9fcab6be5c46bca104d491c990d3ae

Zobrazit plný text záznamu

Matching-adjusted indirect comparison of phase 3 clinical trial outcomes of OC-01 (varenicline solution) nasal spray and lifitegrast 5% ophthalmic solution for the treatment of dry eye disease

Autor: Darrell E, White, Laura H, Hendrix, Lucille, Sun, Iris, Tam, Marian, Macsai, Andrea A, Gibson

Publikováno v: Journal of Managed Care & Specialty Pharmacy. 29:69-79

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::167cf45815da4246226d2384cb88c417
https://doi.org/10.18553/jmcp.2022.22208

Zobrazit plný text záznamu

Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?

Autor: John D. Sheppard, Leslie E. O'Dell, Paul M. Karpecki, Michael B. Raizman, Walter O. Whitley, Gretchen Blemker, Mandy Hemphill, Laura H. Hendrix, Andrea Gibson, Marian Macsai

Publikováno v: Optometry and Vision Science. 100:164-169

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0d98ecfa15907c7faa22e866bc5acb09
https://doi.org/10.1097/opx.0000000000001986

Zobrazit plný text záznamu

Does Menopausal Status Affect Dry Eye Disease Treatment Outcomes with OC-01 (Varenicline Solution) Nasal Spray? A Post Hoc Analysis of ONSET-1 and ONSET-2 Clinical Trials

Autor: Lisa M. Nijm, Dagny Zhu, Mandy Hemphill, Gretchen L. Blemker, Laura H. Hendrix, Alan G. Kabat, Andrea A. Gibson

Publikováno v: Ophthalmology and Therapy. 12:355-364

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3b0f48a47cb981fc484af1f7bd6418d8
https://doi.org/10.1007/s40123-022-00607-7

Zobrazit plný text záznamu

Bilateral Effect of OC-01 (Varenicline Solution) Nasal Spray for Treatment of Signs and Symptoms in Individuals with Mild, Moderate, and Severe Dry Eye Disease

Autor: James Katz, Laura M. Periman, Sathi Maiti, Enrica Sarnicola, Mandy Hemphill, Alan G. Kabat, Laura H. Hendrix, Puja Shah, Andrea Gibson

Publikováno v: Clinical Therapeutics. 44:1463-1470

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4f984c0d2e22836dba078abf75c73ff3
https://doi.org/10.1016/j.clinthera.2022.09.013

Zobrazit plný text záznamu

Safety, adherence and discontinuation in varenicline solution nasal spray clinical trials for dry eye disease

Autor: Scott G Hauswirth, Alan G Kabat, Mandy Hemphill, Karan Somaiya, Laura H Hendrix, Andrea A Gibson

Publikováno v: Journal of Comparative Effectiveness Research. 12

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::20957d281a8fdeb57067454c4c63d0a4
https://doi.org/10.57264/cer-2022-0215

Zobrazit plný text záznamu

Matching-adjusted indirect comparison of phase 3 clinical trial outcomes: OC-01 (varenicline solution) nasal spray and cyclosporine a 0.05% ophthalmic emulsion for the treatment of dry eye disease

Autor: Denise M Visco, Laura H Hendrix, Lucille Sun, Iris Tam, Marian Macsai, Andrea A Gibson

Publikováno v: Journal of managed carespecialty pharmacy. 28(8)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6ce240095d246de8db93962295d4495
https://pubmed.ncbi.nlm.nih.gov/35687793

Zobrazit plný text záznamu

Abstract P1-21-07: The Patient-reported Outcomes after Routine Treatment of Atypical Lesions (PORTAL) study: Pain, psychosocial wellbeing, and quality of life among women undergoing guideline concordant care for DCIS vs. active surveillance for in situ and atypical lesions

Autor: Laura H. Hendrix, Shoshana M. Rosenberg, Deborah Collyar, Thomas R. Lynch, Terry Hyslop, Ann H. Partridge, Jeffrey R. Marks, Kristin L. Schreiber, Elizabeth S. Frank, Desiree Basila, Conor R. Lanahan, Sonja Darai, Alastair M. Thompson, Jennifer K. Plichta, Kevin S. Hughes, E. Shelley Hwang, Isabelle Bedrosian

Publikováno v: Cancer Research. 80:P1-21

Background: Guideline-concordant care (GCC) for DCIS includes surgery, radiation, and endocrine treatment. Active surveillance (AS) is a strategy under study for management of low risk DCIS. The PORTAL Study was designed to evaluate patient reported

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f30bbfa81913696293eed5cd1a9a2d38
https://doi.org/10.1158/1538-7445.sabcs19-p1-21-07

Zobrazit plný text záznamu

Incidence of Ductal Carcinoma In Situ in the United States, 2000–2014

Autor: Yiling Liu, E. Shelley Hwang, Marc D. Ryser, Laura H. Hendrix, Mathias Worni, Terry Hyslop

Publikováno v: Cancer Epidemiology, Biomarkers & Prevention. 28:1316-1323

Background: In absence of definitive molecular risk markers, clinical management of patients diagnosed with ductal carcinoma in situ (DCIS) remains largely guided by patient and tumor characteristics. In this study, we analyzed recent trends in DCIS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7168e14fa925468eb1593a7311b6a83d
https://doi.org/10.1158/1055-9965.epi-18-1262

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání